Dr. Leslie Barakat, a pediatrician and senior medical director for Cigna, has advice about keeping children as safe as possible now that they are back in the classroom.

We sat down with Cigna's Dr. Alla Zilbering to explore the health barriers that the senior population faces, as well as what providers and the health care industry as a whole should be doing to reduce gaps in care and improve health outcomes for all Americans.

The Great Resignation isn’t over. Explore some statistics that can help us reflect on the current state of our workforce, look ahead to the forces redefining work as we know it, and better understand how companies and employees alike are changing their priorities in the wake of this massive shift taking place.

As virtual health care continues to grow, physicians and patients are utilizing technology to build relationships. We interviewed Dr. Vontrelle Roundtree, MDLIVE’s interim chief medical officer, to share her thoughts about the doctor-patient relationship and how it can thrive with virtual care.

Sachin Joshi, chief data and analytics engineering officer at Evernorth, recently sat down at VentureBeat Transform 2022 to discuss the ways Cigna is using data science, predictive modeling, and machine learning to improve patient health outcomes, reduce costs, and fix a fragmented health care system.

Monkeypox, also called MPX, has been making headlines as of late. But, what exactly is Monkeypox? How did it come about, and what does it look like when a person contracts it? We tapped the expertise of Dr. Mark Netoskie, a market medical executive at Cigna, to answer these questions and more.

If you’ve ever been confused by a health insurance term such as coinsurance, deductible, or premium – to name a few – you are not alone. We take a look at some of the most common health insurance terms, what they mean, how insurance works, and the differences in the types of coverage out there.

Americans with employer-sponsored health insurance want plans that cover behavioral and physical health care needs, according to a new AHIP survey.

Scams are rampant in today’s world, in health care and other areas. While anyone of any age can be targeted, older adults are particularly at risk. Last year, fraud cost U.S. seniors more than $1.5 billion. Here is some advice that can help older adults – and younger people, too – protect themselves from scams.

Biosimilars represent a meaningful opportunity to reduce drug spending by as much as $375 billion over the next decade. Cigna is committed to driving greater value and lower costs where clinically appropriate for our customers and clients. As a longtime advocate for greater availability of biosimilars, we have worked for a decade to advance the pathways needed to bring biosimilars to market.